Published by Josh White on 17th June 2024
(Sharecast News) - Hutchmed China announced the publication of positive results from its phase three 'ESLIM-01' trial of sovleplenib in the Lancet Haematology.
URL: http://www.digitallook.com/dl/news/story/34365659/...